Business Description
Medeon Biodesign Inc
ISIN : TW0006499007
Description
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 10.79 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.19 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 15.33 | |||||
Beneish M-Score | -1.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.3 | |||||
3-Year EBITDA Growth Rate | -18.3 | |||||
3-Year EPS without NRI Growth Rate | -15.8 | |||||
3-Year FCF Growth Rate | -2.6 | |||||
3-Year Book Growth Rate | -26.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.72 | |||||
9-Day RSI | 41.92 | |||||
14-Day RSI | 40.19 | |||||
3-1 Month Momentum % | -13.78 | |||||
6-1 Month Momentum % | -19.94 | |||||
12-1 Month Momentum % | -42.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.21 | |||||
Quick Ratio | 8.06 | |||||
Cash Ratio | 7.58 | |||||
Days Inventory | 29.14 | |||||
Days Sales Outstanding | 43.87 | |||||
Days Payable | 12.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | -5.42 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 14.03 | |||||
Operating Margin % | -172.25 | |||||
Net Margin % | -159.28 | |||||
EBITDA Margin % | -145.12 | |||||
FCF Margin % | -154.02 | |||||
OCF Margin % | -150 | |||||
ROE % | -50.48 | |||||
ROA % | -40.51 | |||||
ROIC % | -127.98 | |||||
3-Year ROIIC % | 12.12 | |||||
ROC (Joel Greenblatt) % | -228.88 | |||||
ROCE % | -48.85 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 15.61 | |||||
PB Ratio | 4.66 | |||||
Price-to-Tangible-Book | 5.2 | |||||
EV-to-EBIT | -8.15 | |||||
EV-to-EBITDA | -9.59 | |||||
EV-to-Revenue | 13.92 | |||||
EV-to-FCF | -9.04 | |||||
Price-to-GF-Value | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 6.76 | |||||
| Price-to-Net-Cash | 7.51 | |||||
Earnings Yield (Greenblatt) % | -12.27 | |||||
FCF Yield % | -9.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medeon Biodesign Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 419.425 | ||
| EPS (TTM) (NT$) | -7.239 | ||
| Beta | 0.4732 | ||
| 3-Year Sharpe Ratio | 0.29 | ||
| 3-Year Sortino Ratio | 1.04 | ||
| Volatility % | 29.18 | ||
| 14-Day RSI | 40.19 | ||
| 14-Day ATR (NT$) | 2.742353 | ||
| 20-Day SMA (NT$) | 72.13 | ||
| 12-1 Month Momentum % | -42.76 | ||
| 52-Week Range (NT$) | 67.8 - 134 | ||
| Shares Outstanding (Mil) | 96.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medeon Biodesign Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medeon Biodesign Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.04999:1 Stock Split | 2023-08-23 | 48.29 (-0.39%) | ||
| 1.2:1 Stock Split | 2022-08-22 | 57.14 (-0.68%) | ||
| 1.1:1 Stock Split | 2021-08-23 | 52.73 (+1.51%) | ||
| 1.09992:1 Stock Split | 2019-07-05 | 54.56 (-0.12%) |
Show
Entries
Medeon Biodesign Inc Frequently Asked Questions
What is Medeon Biodesign Inc(ROCO:6499)'s stock price today?
The current price of ROCO:6499 is NT$71.00. The 52 week high of ROCO:6499 is NT$134.00 and 52 week low is NT$67.80.
When is next earnings date of Medeon Biodesign Inc(ROCO:6499)?
The next earnings date of Medeon Biodesign Inc(ROCO:6499) is .
Does Medeon Biodesign Inc(ROCO:6499) pay dividends? If so, how much?
Medeon Biodesign Inc(ROCO:6499) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medeon Biodesign Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers